Pathogens, toxins, and autoantigens bound by Fab regions

Pathogens, toxins, and autoantigens bound by Fab regions represent a broad functional category of molecular entities recognized by the adaptive immune system and targeted by antibody-based therapies. The Fragment antigen-binding (Fab) region is the portion of an antibody molecule that confers specificity, containing the variable domains that form the binding site for a specific epitope on an antigen (Janeway et al., Immunobiology, 2001). In clinical pharmacology, this category includes a diverse array of targets such as viral proteins, bacterial toxins, pro-inflammatory cytokines like TNF-alpha, and small molecule drugs like digoxin or dabigatran (Nelson, Nature Reviews Drug Discovery, 2010; Pollack et al., NEJM, 2015). Drugs designed to interact with these targets, such as monoclonal antibodies or engineered Fab fragments, work by neutralizing the target's toxicity or blocking its ability to bind to physiological receptors. Because this term aggregates thousands of unrelated molecular species across infectious, oncological, and autoimmune disciplines, it is classified as a functional description of antigen-antibody interaction rather than a single discrete therapeutic target.

Other names

AntigensEpitopesFab-binding targetsImmunogensAntibody targets

Therapeutic Fab fragments or full-length antibodies bind to these targets via the variable regions (paratopes) to induce steric hindrance, neutralize biological activity, prevent receptor-ligand interactions, or facilitate clearance from circulation (Janeway et al., Immunobiology, 2001; Nelson, Nature Reviews Drug Discovery, 2010).